ArticleInternational journal of molecular sciences2026

CSL305: A Dual Functional Therapeutic Antibody Targeting Complement C2 and FcRn.

Sandra Wymann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.